The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Vascular System: Role of Nitric Oxide in Cardiovascular Diseases
Open accessAbstract
In contrast with the short research history of the enzymatic synthesis of nitric oxide (NO), the introduction of nitrate-containing compounds for medicinal purposes marked its 150th anniversary in 1997. Glyceryl trinitrate (nitroglycerin) is the first compound of this category. On October 12, 1998, the Nobel Assembly awarded the Nobel Prize in Medicine or Physiology to scientists Robert Furchgott, Louis Ignarro, and Ferid Murad for their discoveries concerning NO as a signaling molecule in the cardiovascular system. NO-mediated signaling is a recognized component in various physiologic processes (eg, smooth muscle relaxation, inhibition of platelet and leukocyte aggregation, attenuation of vascular smooth muscle cell proliferation, neurotransmission, and immune defense), to name only a few. NO has also been implicated in the pathology of many inflammatory diseases, including arthritis, myocarditis, colitis, and nephritis and a large number of pathologic conditions such as amyotrophic lateral sclerosis, cancer, diabetes, and neurodegenerative diseases. Some of these processes (eg, smooth muscle relaxation, platelet aggregation, and neurotransmission) require only a brief production of NO at low nanomolar concentrations and are dependent on the recruitment of cyclic guanosine monophosphate (cGMP)-dependent signaling. Other processes are associated with direct interaction of NO or reactive nitrogen species derived from it with target proteins and requires a more sustained production of NO at higher concentrations but do not involve the cGMP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is well known that endothelium-derived nitric oxide (NO) plays an important role in vascular homeostasis and cardiac function based on seminal studies leading to the Nobel Prize in Physiology or Medicine in 1998 [9, 10].”
From Inorganic nitrite therapy: historical perspective and future directions (2011) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633
Extensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by Immunohistochemistry
Beckman, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., & White, C. R. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.2.81 · Cited by 1,122
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
Zhang, J., Bottiglieri, T., & McCullough, P. A. (2016) · Cardiorenal Medicine · doi:10.1159/000452283 · Cited by 1,084
Cyclic guanosine monophosphate as a mediator of vasodilation.
Murad, F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112536 · Cited by 799
Self-citationPanza, J. A., Casino, P. R., Kilcoyne, C. M., & Quyyumi, A. A. (1993) · Circulation · doi:10.1161/01.cir.87.5.1468 · Cited by 707
Katsuki, S., Arnold, W. P., Mittal, C. K., & Murad, F. (1977) · PubMed · Cited by 700
Self-citationIdentification of the enzymatic mechanism of nitroglycerin bioactivation
Chen, Z., Zhang, J., & Stamler, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122225199 · Cited by 545
Calver, A., Collier, J., & Vallance, P. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116149 · Cited by 522
Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues
Bryan, N. S., Fernandez, B. O., Bauer, S. M., Garcia-Saura, M. F., Milsom, A. B., Rassaf, T., Maloney, R. E., Bharti, A., Rodriguez, J., & Feelisch, M. (2005) · Nature Chemical Biology · doi:10.1038/nchembio734 · Cited by 518
Leeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P. D., Oh‐ishi, S., Steinbrecher, U. P., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1433 · Cited by 461
Protein Nitration in Cardiovascular Diseases
Turko, I. V., & Murad, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.619 · Cited by 378
Self-citationThe loss of endothelium-dependent vascular relaxation in hypertension.
Lockette, W. E., Otsuka, Y., & Carretero, O. A. (1986) · Hypertension · doi:10.1161/01.hyp.8.6_pt_2.ii61 · Cited by 372
A Short History Of Nitroglycerine And Nitric Oxide In Pharmacology And Physiology
Marsh, N., & Marsh, A. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03240.x · Cited by 265
Motoyama, T., Okamoto, K., Kukita, I., Hamaguchi, M., Kinoshita, Y., & Ogawa, H. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000055371.27268.36 · Cited by 207
Structure–Function Relationships in Heme-Proteins
Paoli, M., Marles‐Wright, J., & Smith, A. (2002) · DNA and Cell Biology · doi:10.1089/104454902753759690 · Cited by 199
Stamler, J. S., Simon, D. I., Jaraki, O., Osborne, J. A., Francis, S., Mullins, M. E., Singel, D. J., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8087 · Cited by 185
The nature of heme/iron-induced protein tyrosine nitration
Bian, K., Gao, Z., Weisbrodt, N. W., & Murad, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931291100 · Cited by 179
Self-citationClaudio Napoli, A., Sica, V., de Nigris, F., Pignalosa, O., Condorelli, M., Ignarro, L. J., & Liguori, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.025 · Cited by 175
Nitric oxide NO - biogeneration regulation and relevence to human diseases
Bian, K. (2003) · Frontiers in bioscience · doi:10.2741/997 · Cited by 165
Self-citationDynamic state of S-nitrosothiols in human plasma and whole blood
Jourd’heuil, D., Hallén, K., Feelisch, M., & Grisham, M. B. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00257-9 · Cited by 156
Nitric Oxide Synthesis and Oxidative Stress in the Renal Cortex of Rats with Diabetes Mellitus
Ishii, N., Patel, K. P., Lane, P. H., Taylor, T. A., Bian, K., Murad, F., Pollock, J. S., & Carmines, P. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1281630 · Cited by 149
Self-citationThe vasodilatory beta-blockers
Pedersen, M. E. F., & Cockcroft, J. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0050-2 · Cited by 148
Metabolic Profile of Nebivolol, a ??-Adrenoceptor Antagonist with Unique Characteristics
Rosei, E. A., & Rizzoni, D. (2007) · Drugs · doi:10.2165/00003495-200767080-00001 · Cited by 112
Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., Pasini, A. F., Garbin, U., Cominacini, L., & Salvetti, A. (2001) · Journal of Hypertension · doi:10.1097/00004872-200108000-00005 · Cited by 105
The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress
Scribner, A. W., Loscalzo, J., & Claudio Napoli, A. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.002 · Cited by 93
Wilson, S. K. (1990) · Circulation Research · doi:10.1161/01.res.66.3.722 · Cited by 73
Patel, R. P. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00259-8 · Cited by 71
Ignarro, L. J., Kadowitz, P. J., & Baricos, W. H. (1981) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(81)90125-9 · Cited by 68
Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells
Papapetropoulos, A., Go, C. Y., Murad, F., & Catravas, J. D. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15167.x · Cited by 67
Self-citationNitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry
Bian, K., Davis, K. L., Kuret, J., Binder, L. I., & Murad, F. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.1.f33 · Cited by 62
Self-citationProtein tyrosine nitration and peroxynitrite
Deen, W. M., Tannenbaum, S. R., & Beckman, J. S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0133lte · Cited by 56
Bennett, B. M., Schröder, H., Hayward, L. D., Waldman, S. A., & Murad, F. (1988) · Circulation Research · doi:10.1161/01.res.63.4.693 · Cited by 53
Self-citationWillerson, J. T., & Kereiakes, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000099580.72044.83 · Cited by 41
Asatryan, L., Ziouzenkova, O., Duncan, R., & Sevanian, A. (2003) · Blood · doi:10.1182/blood-2003-01-0293 · Cited by 33
The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats
Jia, L., & Blantz, R. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00424-5 · Cited by 29
Gil‐Longo, J., Fdez-Grandal, D., Alvarez, M. F., Sieira, M., & Orallo, F. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00392-5 · Cited by 23
Akiba, Y., Yamaguchi, N., Amano, H., Fujii, T., Fujimoto, K., Suzuki, T., & Kawashima, K. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb02855.x · Cited by 23
Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum
Reidenbach, C., Schwinger, R. H. G., Steinritz, D., Kehe, K., Thiermann, H., Klotz, T., Sommer, F. O., Bloch, W., & Brixius, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.016 · Cited by 22
Lewis, S. J., Hashmi-Hill, M. P., Owen, J. R., Sandock, K., Robertson, T. P., & Bates, J. N. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.03.003 · Cited by 13
Shou, I., Fukui, M., & Tomino, Y. (2001) · KARGER eBooks · doi:10.1159/000060135 · Cited by 4
Cited by
Sorted by citations
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 884
Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms
Laakso, M. (2010) · Diabetes Care · doi:10.2337/dc09-0749 · Cited by 306
Lehnert, N., Kim, E., Dong, H. T., Harland, J. B., Hunt, A. P., Manickas, E. C., Oakley, K. M., Pham, J., Reed, G. C., & Alfaro, V. S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00253 · Cited by 283
Graphene Oxides Show Angiogenic Properties
Mukherjee, S., Sriram, P., Barui, A. K., Nethi, S. K., Veeriah, V., Chatterjee, S., Suresh, K. I., & Patra, C. R. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500155 · Cited by 224
Naringenin and naringin in cardiovascular disease prevention: A preclinical review
Moghaddam, R. H., Samimi, Z., Moradi, S. Z., Little, P. J., Xu, S., & Farzaei, M. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173535 · Cited by 220
Metadata
- Authors
- Bian, K., Doursout, M., & Murad, F.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Murad, Ferid
- Venue
- The Journal of Clinical Hypertension
- Publisher
- Wiley
- Published
- 2008-04
- Volume
- 10
- Issue
- 4
- Pages
- 304-310
- ISSN
- 1524-6175 (ISSN-L)
- 1751-7176
- PMC
- PMC8109995
- OpenAlex
- W2004742560
- Semantic Scholar
- 3f0ea8307ce77731d0e60b1fcc78d664629064bb
- Cited by
- 229
- References
- 41
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 12 · 2016: 13 · 2015: 20 · 2014: 16 · 2013: 14 · 2012: 19
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Hypertension (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM061731, R01GM061731)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- nitric oxide, cardiovascular disease, nitric oxide signaling, nitroglycerin, reactive nitrogen species, smooth muscle relaxation, platelet aggregation, vascular smooth muscle cell proliferation, inflammation
- MeSH terms
- Cardiovascular Agents, Cardiovascular Diseases, Cardiovascular System, Endothelium, Humans, Hypertension, Nitric Oxide, Signal Transduction, Reactive Oxygen Species, Reactive Nitrogen Species, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
